News|Articles|April 19, 2024

“It Takes a Village”: Preventing MDRO Spread Through Public Health Partnerships

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

Preventing the spread of multidrug-resistant organisms (MDROs) must be a collaborative effort between public health departments and health care facilities. However, how can that be done effectively?

Tisha Mitsunaga, DrPH, ScM, the Prevention Epidemiology Team Lead for the California Department of Public Health’s Healthcare-Associated Infections Program, Richmond, California, speaks with Infection Control Today® (ICT®) about her presentation on this topic.

She will give her presentation, “Prevention Collaboratives Involving Public Health Departments and Healthcare Facilities,” at the Society of Epidemiology of America in Houston, Texas, held from April 16 to 19, 2024.


ICT: What inspired you to choose the topics for your presentation at the SHEA conference this year?
Tisha Mitsunaga, DrPH, ScM: While the California Department of Health Healthcare-Associated Infections Program does a lot of great work with prevention activities across the state, I’m particularly proud of our regional multidrug-resistant organism (MDRO) prevention collaboratives that have used multidisciplinary and innovative approaches to engage health care facilities in this effort. This goes beyond education and training on infection prevention and control practices but also includes supporting antimicrobial stewardship and strengthening laboratory testing using peer-to-peer learning and convening hospitals and skilled nursing facilities (SNFs) in the same room to discuss challenges and opportunities to collaborate to address these challenges.

ICT: Could you elaborate on the key points or takeaways you aimed to deliver to the audience during your session?
TM: I’d like the audience to understand that health care facilities are part of a broader health care community, and therefore, it takes a village to prevent the spread of MDROs like Candida auris in health care settings. That is, public health, with the help of hospitals and nursing homes, can support a multipronged approach, including enhanced detection through clinical isolate testing and colonization screening, infection prevention and control (IPC), and antimicrobial stewardship activities. Communication plays a key role in stakeholder collaboration and coordination of these efforts.

Additionally, there are free public health resources to complement this approach, including webinars and other educational offerings, and laboratory testing services. One successful example of a partnership in practice is public health, which works with hospitals to implement screening patients for C auris upon admission. Through this process, hospitals have identified patients with C auris not previously known to be colonized, potentially preventing the spread at both the admitting and discharging facilities.

ICT: In your opinion, what are the most significant challenges that epidemiologists and other infection prevention personnel face today, and how does your presentation address these challenges?
TM: One challenge we face is being prepared to detect and respond to the next big health care-associated pathogen—today it might be C auris, but tomorrow it could be something new. I believe the principles behind the multi-pronged approach I lay out in the presentation can provide a great foundation for epidemiologists, infection prevention personnel, and other health care personnel to contain any new MDRO: robust surveillance systems; strong core infection prevention and control practices; antimicrobial stewardship programs; and communication, collaboration and coordination among public health and health care facilities can set us up to succeed now and in the future.

ICT: Do you have anything you’d like to add?
TM: I’d like to recognize all of my colleagues who have contributed to this effort and thank our health care partners for helping us prevent the spread of MDROs—we couldn’t do it without them. I’d also like to encourage all hospitals and SNFs to engage with and support their public health departments and take advantage of the free educational and testing resources available.

Resource:

Mitsunaga, T. Prevention Collaboratives Involving Public Health Departments and Healthcare Facilities.Poster was presented at SHEA 2024. April 16-19, 2024. Houston, TX.


Related to this article

Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
A group of students raising their hands in class during a lecture  (Adobe Stock 292282454 by Mediteraneo
How do you celebrate an infection that never happened? That's one of the unusual challenges infection preventionists share with teachers. Both can spend their careers changing outcomes they may never see. Both educate people who don't always want to listen. Both are second-guessed. Both face burnout. And both must somehow keep remembering why they started.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
Can a UV-C robot make up for a surface that wasn't properly cleaned? Experts say that's the wrong way to think about the technology. UV-C can provide an additional layer of microbial reduction, but factors including shadows, distance, positioning, and exposure time mean it cannot replace thorough manual cleaning and disinfection.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.
Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)
“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.